View in EDS HTML Full Text PDF Full Text

CXCR7 activation evokes the anti-PD-L1 antibody against glioblastoma by remodeling CXCL12-mediated immunity.

Saved in:
Bibliographic Details
Title: CXCR7 activation evokes the anti-PD-L1 antibody against glioblastoma by remodeling CXCL12-mediated immunity.
Authors: Liu CC; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan., Yang WB; Research Center for Neuroscience, Taipei Medical University, Taipei, Taiwan.; Ph.D. Program in Medical Neuroscience, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan., Chien CH; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.; School of Medicine, I-Shou University, Kaohsiung, Taiwan., Wu CL; Department of Pathology, National Cheng Kung University Hospital, College of Medicine, National Cheng-Kung University, Tainan, Taiwan., Chuang JY; Research Center for Neuroscience, Taipei Medical University, Taipei, Taiwan.; International Master Program in Medical Neuroscience, Taipei Medical University, Taipei, Taiwan.; Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Kaohsiung, Taiwan., Chen PY; School of Medicine, Chang Gung University, Taoyuan, Taiwan.; Department of Neurosurgery, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan., Chu JM; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan., Cheng SM; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan., Qiu LY; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan., Chang YC; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.; TMU Research Center of Cancer Translational Medicine; Taipei Cancer Center; Taipei Medical University Hospital, College of Medicine, Taipei Medical University, Taipei, Taiwan., Hwang DY; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan., Huang CY; Division of Neurosurgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Lee JS; Division of Neurosurgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Chang KY; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan. kwang2@nhri.edu.tw.; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. kwang2@nhri.edu.tw.; Center of Cell Therapy, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. kwang2@nhri.edu.tw.
Source: Cell death & disease [Cell Death Dis] 2024 Jun 19; Vol. 15 (6), pp. 434. Date of Electronic Publication: 2024 Jun 19.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38898023
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: CXCR7 activation evokes the anti-PD-L1 antibody against glioblastoma by remodeling CXCL12-mediated immunity.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Liu+CC%22">Liu CC</searchLink>; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Yang+WB%22">Yang WB</searchLink>; Research Center for Neuroscience, Taipei Medical University, Taipei, Taiwan.; Ph.D. Program in Medical Neuroscience, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chien+CH%22">Chien CH</searchLink>; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.; School of Medicine, I-Shou University, Kaohsiung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Wu+CL%22">Wu CL</searchLink>; Department of Pathology, National Cheng Kung University Hospital, College of Medicine, National Cheng-Kung University, Tainan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chuang+JY%22">Chuang JY</searchLink>; Research Center for Neuroscience, Taipei Medical University, Taipei, Taiwan.; International Master Program in Medical Neuroscience, Taipei Medical University, Taipei, Taiwan.; Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Kaohsiung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chen+PY%22">Chen PY</searchLink>; School of Medicine, Chang Gung University, Taoyuan, Taiwan.; Department of Neurosurgery, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chu+JM%22">Chu JM</searchLink>; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Cheng+SM%22">Cheng SM</searchLink>; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Qiu+LY%22">Qiu LY</searchLink>; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chang+YC%22">Chang YC</searchLink>; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.; TMU Research Center of Cancer Translational Medicine; Taipei Cancer Center; Taipei Medical University Hospital, College of Medicine, Taipei Medical University, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Hwang+DY%22">Hwang DY</searchLink>; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Huang+CY%22">Huang CY</searchLink>; Division of Neurosurgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lee+JS%22">Lee JS</searchLink>; Division of Neurosurgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chang+KY%22">Chang KY</searchLink>; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan. kwang2@nhri.edu.tw.; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. kwang2@nhri.edu.tw.; Center of Cell Therapy, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. kwang2@nhri.edu.tw.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101524092%22">Cell death & disease</searchLink> [Cell Death Dis] 2024 Jun 19; Vol. 15 (6), pp. 434. <i>Date of Electronic Publication: </i>2024 Jun 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101524092 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-4889 (Electronic) <i>NLM ISO Abbreviation: </i>Cell Death Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38898023
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41419-024-06784-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 434
    Titles:
      – TitleFull: CXCR7 activation evokes the anti-PD-L1 antibody against glioblastoma by remodeling CXCL12-mediated immunity.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Liu CC
      – PersonEntity:
          Name:
            NameFull: Yang WB
      – PersonEntity:
          Name:
            NameFull: Chien CH
      – PersonEntity:
          Name:
            NameFull: Wu CL
      – PersonEntity:
          Name:
            NameFull: Chuang JY
      – PersonEntity:
          Name:
            NameFull: Chen PY
      – PersonEntity:
          Name:
            NameFull: Chu JM
      – PersonEntity:
          Name:
            NameFull: Cheng SM
      – PersonEntity:
          Name:
            NameFull: Qiu LY
      – PersonEntity:
          Name:
            NameFull: Chang YC
      – PersonEntity:
          Name:
            NameFull: Hwang DY
      – PersonEntity:
          Name:
            NameFull: Huang CY
      – PersonEntity:
          Name:
            NameFull: Lee JS
      – PersonEntity:
          Name:
            NameFull: Chang KY
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 06
              Text: 2024 Jun 19
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2041-4889
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Cell death & disease
              Type: main
ResultId 1